Medicine and Dentistry
Cytoreductive Surgery
100%
Hyperthermic Intraperitoneal Chemotherapy
94%
Peritoneum Mesothelioma
30%
Peritoneum Metastasis
26%
Diverticulitis
24%
Hepatocellular Carcinoma
22%
CA-125
22%
Carcinomatous Peritonitis
22%
Overall Survival
20%
Neoplasm
20%
Intraperitoneal Chemotherapy
19%
Colorectal Cancer
19%
Malignant Neoplasm
19%
Cancer
18%
Surgery
18%
Colon Diverticulosis
15%
Pancreaticoduodenectomy
15%
Acute Appendicitis
15%
Peritoneum Cancer
12%
Liver Transplantation
10%
Propensity Score Matching
10%
Diagnosis
9%
Metastasectomy
9%
Appendix Tumor
9%
Hepatectomy
9%
Metastatic Carcinoma
9%
Adenocarcinoma
9%
Long Term Survival
9%
Disease
8%
Platelet
8%
Neutrophil
8%
Lymphocyte
8%
Germline Mutation
8%
Sorafenib
8%
Stomach Cancer
8%
Emergency Department
8%
Bilirubin
7%
Biliary Atresia
7%
Programmed Death 1 Ligand 1
7%
Ovarian Cancer
7%
Lymph Node Metastasis
7%
Colorectal Disease
7%
Diverticulum
7%
Liver Enzyme
7%
Venous Thromboembolism
7%
Monocyte
7%
Clinical Guideline
7%
Recurrent Disease
7%
Stoma
7%
Colonoscopy
7%
Keyphrases
Cytoreductive Surgery
95%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
94%
Peritoneal Metastasis
26%
Peritoneal Mesothelioma
22%
Carbohydrate Antigen 125 (CA125)
20%
Systemic Chemotherapy
20%
Acute Diverticulitis
19%
Peritoneal Carcinomatosis
17%
Peritoneal Cancer Index
17%
Peritoneal Surface Malignancy
16%
Propensity Score Matching
16%
CA-125 Levels
15%
Appendiceal
15%
Acute Appendicitis
15%
Laparoscopic Pancreaticoduodenectomy
15%
Colonic Diverticulitis
15%
National Surgical Quality Improvement Program (NSQIP)
15%
Hepatocellular Carcinoma
15%
Overall Survival
10%
Readmission
10%
Diverticulitis
10%
Colorectal Cancer
10%
Intraperitoneal Chemotherapy
10%
Metastasectomy
9%
Postoperative Outcomes
9%
Liver Transplantation
9%
Confidence Interval
9%
Germline mutation
8%
Malignant Peritoneal Mesothelioma
8%
Socioeconomic Factors
8%
Long-term Survival
8%
Median Overall Survival
8%
Liver Resection
8%
Sorafenib
8%
Patient Selection
8%
Pancreaticoduodenectomy
8%
Appendiceal Neoplasms
8%
Postoperative Pancreatic Fistula
8%
Serum CA125
7%
Neoplasms
7%
Total Bilirubin
7%
Locoregional Therapy
7%
Adenocarcinoma
7%
Systemic Recurrence
7%
Liver Involvement
7%
Chemotherapy Outcomes
7%
Intraductal
7%
Lymph Node Metastasis
7%
Hidden Danger
7%
Goblet
7%